Travera offers a new clinical diagnostic test developed at MIT and Dana Farber to predict clinical response to as many as 20 cancer drug therapies against your live cancer cells. You simply have a small sample of your live cancer cells sent to Travera in a special test kit, and two days later, your doctor receives an analysis of cellular response against as many as 20 different drugs, so you can better choose your next bridge therapy.
As a CLIA-approved test, this assay is currently only available in the US and will require an order from your testing physician, but Travera can help you get that order. The test is available via clinical trial or Early Access Program.
If you are expecting to change therapy in the coming weeks or months and can have a sample collected from a simple biopsy or a malignant fluid drain (ascites or pleural effusion). Travera can work with you.
Visit travera.com/bluefaery or call 781-874-0808
